New antibody GEN1079 enters human trials for Hard-to-Treat cancers
NCT ID NCT07387068
First seen Feb 04, 2026 · Last updated May 23, 2026 · Updated 16 times
Summary
This early-stage trial tests a new antibody called GEN1079 in people with certain advanced solid tumors. The study has three parts: first, finding a safe dose; then, refining the dose; and finally, checking how well it works in more patients. About 121 participants will receive the drug, and researchers will monitor safety and tumor response for up to 67 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centro Integral Oncologico Clara Campal
RECRUITINGMadrid, 28050, Spain
-
Hospital Quironsalud Barcelona
RECRUITINGBarcelona, 8023, Spain
-
Hospital Universitario Fundacion Jimenez Diaz
RECRUITINGPozuelo de Alarcón, Madrid, 28223, Spain
-
Hospital Universitario Fundacion Jimenez Diaz
RECRUITINGMadrid, 28040, Spain
-
Hospital Universitario San Pedro
RECRUITINGLogroño, La Rioja, 26006, Spain
-
START Midwest, LLC
RECRUITINGGrand Rapids, Michigan, 49546, United States
-
START New York
RECRUITINGLake Success, New York, 11042, United States
Conditions
Explore the condition pages connected to this study.